Skip to main content

Jordi Lozano Torres

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Jordi Lozano Torres

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Personal Investigador para Grupo Cardiovascular

IP: Ignacio Ferreira González
Collaborators: Alba Santos Ortega, José Antonio Barrabés Riu, Maria Vidal Burdeus, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Teresa González Alujas, Begoña Benito Villabriga, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Victor Gonzalez Fernandez, Guillem Casas Masnou, David Aluja Gonzalez, Bernat Serra Creus, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Aitor Uribarri Gonzalez, Imanol Otaegui Irurueta, Jordi Bañeras Rius, Bruno García del Blanco, Ruperto Olivero Soldevila, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Jordi Lozano Torres, Ana Belén Méndez Fernández, Berta Miranda Barrio, Gerard Oristrell Santamaria, Pau Rello Sabaté, Toni Soriano Colomé, Jaume Francisco Pascual, Aleix Olivella San emeterio, Sara Delgado Tomás, Aroa Ruiz Muñoz, Javier Inserte Igual, Mª Ángeles Carmona Ramírez, Javier Limeres Freire, Irene Buera Surribas, Ruben Fernández Galera, Raul Aguilar Lopez, Alvaro Calabuig Goena, Lydia Dux-Santoy Hurtado, Laura Galián Gay, Laura Dos Subirá, Maria Nazarena Pizzi, Filipa Xavier De Carvalho Negrao Valente, Andrea Guala
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00758
Duration: 01/01/2022 - 30/06/2025

Impact of an exercise-based rehabilitation program in patients with Marfan syndrome on physical, psychological and cardiovascular health

IP: Gisela Teixido Tura
Collaborators: Laura Gutierrez García-Moreno, Jordi Lozano Torres, Alba Gómez Garrido, Lydia Dux-Santoy Hurtado, PATRICIA LAUNOIS OBREGÓN, Filipa Xavier De Carvalho Negrao Valente, Raul Aguilar Lopez
Funding agency: Instituto de Salud Carlos III
Funding: 45375
Reference: PI21/00448
Duration: 01/01/2022 - 30/06/2026

Rehab+

IP: Jordi Lozano Torres
Collaborators: -
Funding agency: EIT- European Institute of Innovation & Technolog
Funding: 55865.85
Reference: REHAB+_EIT HEALTH2020
Duration: 01/01/2021 - 31/12/2022

Evaluación de la efectividad del seguimiento mediante app de pacientes atendidos en una Consulta de Rehabilitación y Control de Riesgo Cardiovascular

IP: Ignacio Ferreira González
Collaborators: Aida Ribera Sole, Jordi Lozano Torres, Gerard Oristrell Santamaria, Javier Limeres Freire
Funding agency: Fundación Merck Salud
Funding: 10000
Reference: MERCK2019/IFERREIRA
Duration: 02/12/2019 - 02/12/2021

Related news

The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.

In light of this evidence, hospitals such as Vall d'Hebron have already started to include warnings about environmental pollution in their hospital discharge plans after a myocardial infarction.

Vall d'Hebron researchers have created a score based on multiple clinical variables and cardiac images, specific to women, to identify patients at risk of severe complications such as a heart attack or sudden death.

Related professionals

Andrea Villar Menendez

Andrea Villar Menendez

Tècnic/a Grau Superior
International Unit
Competitive Research Directorate
Read more
Albert Blanco Grau

Albert Blanco Grau

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Júlia Laborda Aylagas

Júlia Laborda Aylagas

Research technician
Maternal and Fetal Medicine
Read more
Antonio Álvarez Fernandez

Antonio Álvarez Fernandez

Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.